Categories: News

Golden Suisse and Professor Joseph Stiglitz Convene Global UHNWI Summit

ZURICH, Sept. 25, 2025 /PRNewswire/ — On September 10th, Golden Suisse hosted an exclusive blacktie private wealth event at Zurich’s prestigious The Dolder Grand, welcoming more than 150 distinguished Ultra-High-Net-Worth Individuals (UHNWIs) and family office leaders from over 80 countries.

- Advertisement -

The keynote address was delivered by Professor Joseph Stiglitz, Nobel Prizewinning economist, World Bank authority, and one of the world’s top 100 most influential thinkers. Also speaking was Daniel Weitmann, founder of Golden Suisse, who outlined the company’s mission to restore stability, security, privacy, and sovereignty in Swiss banking.

- Advertisement -

Discussions centered on the growing fragility of the global banking system, the erosion of the U.S. dollar, and the increasing politicization of money and payment infrastructures.

- Advertisement -

Professor Stiglitz noted: “All currencies and banks are ultimately based on trust. Once that trust erodes, the entire financial system is at risk.”

- Advertisement -

Daniel Weitmann responded: “Golden Suisse removes the uncertainty of trust by anchoring money directly to physical gold, stored privately in Switzerland and usable worldwide. This is not just about wealth — it is about sovereignty and freedom.”

- Advertisement -

Golden Suisse presented its model, rooted in Switzerland’s centuries-old bullion vaulting traditions and enhanced with modern banking systems. The platform enables clients to use their privately vaulted gold in Switzerland for global payments, transfers, and card transactions. By bridging physical gold with modern financial rails, Golden Suisse is reviving the heritage of the gold standard while upholding the timeless values of Swiss privacy and neutrality.

- Advertisement -

This landmark gathering underscored Golden Suisse’s role as a leader in shaping the future of wealth protection for the world’s most prominent families.

- Advertisement -

Multimedia: 

- Advertisement -

Watch the film “Golden Suisse — The Essence” (Director: Philip Walsch):

- Advertisement -

https://youtu.be/SULexj0sPMc?si=EUkiQg6Ozlyl_Rbu

- Advertisement -

About Golden Suisse

- Advertisement -

Golden Suisse is a Swiss financial group specializing in vaulted gold, private wealth management, and asset protection. Founded on principles of neutrality, discretion, and independence, Golden Suisse provides secure and sovereign solutions for wealth preservation in an era of uncertainty. Learn more at https://www.goldensuisse.com

- Advertisement -

support@goldensuisse.com 

- Advertisement -

Video – https://www.youtube.com/watch?v=SULexj0sPMc
Photo – https://mma.prnewswire.com/media/2779677/Golden_Suisse_1.jpg
Photo – https://mma.prnewswire.com/media/2779678/Golden_Suisse_2.jpg
Photo – https://mma.prnewswire.com/media/2779679/Golden_Suisse_3.jpg
Photo – https://mma.prnewswire.com/media/2779680/Golden_Suisse_4.jpg
Photo – https://mma.prnewswire.com/media/2779681/Golden_Suisse_5.jpg
Photo – https://mma.prnewswire.com/media/2779682/Golden_Suisse_6.jpg
Logo – https://mma.prnewswire.com/media/2583175/5525069/Golden_Suisse_Logo.jpg

- Advertisement -

 

- Advertisement -

 

- Advertisement -

 

- Advertisement -

 

- Advertisement -

 

- Advertisement -

 

- Advertisement -

 

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/golden-suisse-and-professor-joseph-stiglitz-convene-global-uhnwi-summit-302565060.html

- Advertisement -

Recent Posts

Deepak Group Goes Beyond Green with hands-On Mangrove Restoration

Deepak Group undertakes mangrove plantation drive on World Environment DaySustainable restoration along the Paniyadra coast,…

3 hours ago

Biomea Fusion Presents New Clinical and Translational Data for Icovamenib at the American Diabetes Association (ADA) 86th Scientific Sessions and Announces Expansion of Ongoing Phase I BMF-650 Study

•Translational data presented at ADA demonstrate icovamenib’s potential to promote muscle preservation and fat reduction,…

7 hours ago

Hengrui Pharma and Kailera Therapeutics Present Ribupatide Clinical Data at ADA 2026

Presentations will feature clinical results for ribupatide, a GLP-1/GIP receptor dual agonist being developed as…

7 hours ago

Cullinan Therapeutics Presents Initial Clinical Data for CLN-978, a CD19xCD3 T Cell Engager, at the EULAR 2026 Congress

Clinical benefit, including remissions, demonstrated in both systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA)…

7 hours ago

Bluejay Diagnostics Announces Closing of Up to $23.7 Million Private Placement Priced At-The-Market Under Nasdaq Rules

June 05, 2026 20:13 ET  | Source: Bluejay Diagnostics, Inc. $8.5 million upfront with up…

7 hours ago